MAM

MPM Asset Management Portfolio holdings

AUM $43.3M
This Quarter Return
-4.23%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$560M
AUM Growth
+$560M
Cap. Flow
-$55.2M
Cap. Flow %
-9.86%
Top 10 Hldgs %
99.7%
Holding
17
New
1
Increased
–
Reduced
1
Closed
2

Top Buys

1
AVTX icon
Avalo Therapeutics
AVTX
$2M

Top Sells

1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
$52M
2
NVRO
NEVRO CORP.
NVRO
$4.18M
3
VSTM icon
Verastem
VSTM
$1.03M

Sector Composition

1 Healthcare 32.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$359M 64.04% 5,831,253 – –
CHMA
2
DELISTED
Chiasma, Inc. Common Stock
CHMA
$111M 19.84% 5,681,544 – –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$27.7M 4.94% 1,729,674 – –
TARA icon
4
Protara Therapeutics
TARA
$120M
$15.3M 2.72% 983,381 – –
ALT icon
5
Altimmune
ALT
$338M
$12.1M 2.15% 6,347,614 – –
TRIV
6
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$11.8M 2.11% 1,776,692 – –
NVRO
7
DELISTED
NEVRO CORP.
NVRO
$10.1M 1.81% 150,000 -61,884 -29% -$4.18M
PETX
8
DELISTED
Aratana Therapeutics, Inc.
PETX
$6.24M 1.11% 1,117,875 – –
HSTO
9
DELISTED
Histogen Inc. Common Stock
HSTO
$3.43M 0.61% 1,192,080 – –
AVTX icon
10
Avalo Therapeutics
AVTX
$122M
$2M 0.36% +595,436 New +$2M
SVRA icon
11
Savara
SVRA
$567M
$1.07M 0.19% 2,551,851 – –
SGMO icon
12
Sangamo Therapeutics
SGMO
$157M
$205K 0.04% 22,487 – –
CLCD
13
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$183K 0.03% 21,806 – –
ETRM
14
DELISTED
EnteroMedics Inc.
ETRM
$145K 0.03% 1,113,168 – –
MGNX icon
15
MacroGenics
MGNX
$112M
$98K 0.02% 3,168 – –
VSTM icon
16
Verastem
VSTM
$569M
– – -572,874 Closed -$1.03M
PTLA
17
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– – -1,220,672 Closed -$52M